HIGHLIGHTS
- who: Stephen J. Polyak et al. from the Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA have published the research work: Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure, in the Journal: Pathogens 2021, 44 of /2021/
- how: Similar results were obtained using a mouse model .
SUMMARY
This review summarizes the emerging information on the molecular underpinnings for the persisting risk of liver disease in DAA-cured patients, with a focus on innate immune, epigenetic, gene_expression, and signaling . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.